Unfolding Worldwide Market Opportunity for Cancer Vaccines
Unfolding Worldwide Market Opportunity for Cancer Vaccines
RELEASE DATE
11-Jun-2004
11-Jun-2004
REGION
Global
Global
Research Code: A891-01-00-00-00
SKU: HC00983-GL-MR_04879
$3,950.00
In stock
SKU
HC00983-GL-MR_04879
Description
This research service includes many aspects of the product analysis for the cancer vaccines market including: drivers, restraints, existing market trends, pipeline trends, challenges, strategic company profiles, financial analysis and awards. Prevalence, average selling prices, and revenue forecasts provide market opportunity for cancer vaccines.
Table of Contents
Overview
- Introduction
- Disclaimer
- Certification
- Research Scope And Methodology
- Study Objectives
- Market Segmentation By Cancer Sites
- Market Segmentation By Geographical Regions
- Key Definition-1
- CEO Quote
- Key Definition-2
- Key Definition-3
- Key Definition-4
Market Dynamics
- Industry Challenges
- Radar Screen: Cancer Vaccine Companies
- CEO Quote
Demand Analysis
- Prevalence of Key Cancers (U.S.)
- Prevalence of Key Cancers (E.U.)
- Incidence of Prostate Cancer (World)-1
- Incidence of Prostate Cancer (World)-2
- Incidence of Breast Cancer (World)-1
- Incidence of Breast Cancer (World)-2
- Incidence of Colon Rectum Cancer (World)-1
- Incidence of Colon Rectum Cancer (World)-2
- Key Drivers
- CEO Quote
Pipeline Analysis and Product Profiles
- Cancer Vaccines Pipeline Chart
- Lead Stage Cancer Vaccine Products
- Product Profile: AVICINE
- Product Profile: Canvaxin
- Product Profile: GMK Cancer Vaccine
- Product Profile: MyVax
- Product Profile: Oncophage
- Product Profile: OncoVAX
- Product Profile: Provenge
- Product Profile: Theratope
- CEO Quote
Market Revenue Forecast
- Forecast Assumptions
- Revenue Forecast - Prostate Cancer (U.S.)
- Revenue Forecast - Prostate Cancer (U.S.)
- Revenue Forecast - Breast Cancer (U.S.)
- Revenue Forecast - Melanoma (U.S.)
- Revenue Forecast - Colon Rectum Cancer (U.S.)
- Revenue Forecast - Prostate Cancer (E.U.)
- Revenue Forecast - Breast Cancer (E.U.)
- Revenue Forecast - Colon rectum cancer (E.U.)
- Revenue Forecast - Melanoma (E.U.)
- Total Market Revenue Forecast
- Total World Market For Cancer Vaccines
- Percentage of Revenues by Product Type
- CEO Quote
Company Profile and Strategy Analysis
- Company Profile : Antigenics
- Company Profile : AVI Biopharma
- Company Profile : Biomira
- Company Profile : CancerVax
- Company Profile : Dendreon
- Company Profile : Genitope
- Company Profile : Intracel
- Product Marketing Strategy Analysis
- Cancer vaccines: Technology Challenge
- CEO Quote
Awards
- Introduction
- Entrepreneurial Company Award
- Product Innovation Award
- Technology Leadership Award
Econometrics
- Macro Economic Analysis - I
- Macro Economic Analysis - II
- Macro Economic Analysis - III
- Macro Economic Analysis - IV
Frost & Sullivan
- Healthcare Team
- Our Capabilities
- Key Advantages
- Our Consulting Clients
- Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Service
- Growth Partnership Services Program
Related Research
Popular Topics
This research service includes many aspects of the product analysis for the cancer vaccines market including: drivers, restraints, existing market trends, pipeline trends, challenges, strategic company profiles, financial analysis and awards. Prevalence, average selling prices, and revenue forecasts provide market opportunity for cancer vaccines.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A891-01-00-00-00 |
Is Prebook | No |